Suraksha Diagnostic
NSE: SURAKSHA · ISIN INE877V01027 · Healthcare
₹353.85+10.20 (+2.97%)
Monday 9 November, 12:05 IST. Delayed. Source: Yahoo Finance.
Price chart
₹353.85 +10.20 (+2.97%) today
The day
- Previous close
- ₹343.65
- Open
- ₹343.00
- Day high
- ₹359.50
- Day low
- ₹341.55
Listed on NSE since 6 December 2024.
Key numbers
- Market value
- ₹1,789.76 Cr
- P/E (trailing)
- 49.95
- EPS (trailing)
- ₹6.88
- Price to book
- 7.28
- Dividend yield
- 0.15%
- Debt to equity
- 0.54
- Profit margin
- 11.0%
- Volume today
- 1.01 L
- Average volume
- 1.70 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹190.13 Cr | ₹6.52 Cr |
| FY24 | ₹218.71 Cr | ₹23.63 Cr |
| FY25 | ₹252.09 Cr | ₹31.82 Cr |
| FY26 | ₹310.41 Cr | ₹32.19 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹88 Cr | ₹13 Cr | +38.4% |
| Q4 FY26Jan–Mar 2026Audited | ₹81 Cr | ₹6 Cr | −15.0% |
| Q3 FY26Oct–Dec 2025 | ₹78 Cr | ₹8 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹79 Cr | ₹9 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹73 Cr | ₹9 Cr | – |
| Q4 FY25Jan–Mar 2025Audited | ₹65 Cr | ₹7 Cr | – |
Source: Suraksha Diagnostic’s results filed with NSE, consolidated (the whole group). Net profit is the share of Suraksha Diagnostic’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹229 Cr | ₹169 Cr |
| Investments | ₹0 | ₹0 |
| Inventories | ₹8 Cr | ₹8 Cr |
| Owed by customers | ₹23 Cr | ₹14 Cr |
| Cash and equivalents | ₹3 Cr | ₹2 Cr |
| Total assets | ₹448 Cr | ₹380 Cr |
| Borrowings | ₹2 Cr | ₹3 Cr |
| Total liabilities | ₹205 Cr | ₹151 Cr |
| Shareholders’ equity | ₹245 Cr | ₹230 Cr |
Source: Suraksha Diagnostic’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Suraksha Diagnostic
Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men's and women's health, senior citizens, diabetes care, fever, full-body checkups, and at-home packages. The company was founded in 1992 and is based in Kolkata, India.
- Industry
- Diagnostics & Research
- Based in
- Kolkata
- Employees
- 1,600
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Suraksha Diagnostic in the last day or two.
Dividends and corporate actions
All companies- Dividend - Re 0.50 Per Share
Dividend · ex-date 15 September 2026
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.